CII
RPRX icon

Capital International Inc’s Royalty Pharma RPRX Stock Holding History

Capital International Inc’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.3M Buy
1,074,948
+51,068
+5% +$2.66M 0.42% 60
2026
Q1 		$49.1M Buy
1,023,880
+284,695
+39% +$12.5M 0.38% 70
2025
Q4 		$28.6M Buy
739,185
+58,030
+9% +$2.21M 0.22% 118
2025
Q3 		$24M Buy
681,155
+19,619
+3% +$710K 0.19% 138
2025
Q2 		$23.8M Buy
+661,536
New +$21.9M 0.23% 115
2021
Q4 		– Sell
-614,131
Closed -$22.2M – 311
2021
Q3 		$22.2M Sell
614,131
-223,943
-27% -$8.7M 0.21% 120
2021
Q2 		$34.4M Sell
838,074
-57,611
-6% -$2.45M 0.31% 108
2021
Q1 		$39.1M Sell
895,685
-132,490
-13% -$6.28M 0.36% 102
2020
Q4 		$51.5M Buy
1,028,175
+44,001
+4% +$1.87M 0.48% 77
2020
Q3 		$41.4M Buy
984,174
+421,574
+75% +$18.1M 0.46% 77
2020
Q2 		$27.3M Buy
+562,600
New +$27.8M 0.33% 106

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Inc's RPRX Position: Q2 2026 in Review

Capital International Inc increased its Royalty Pharma (RPRX) stake by 5% in Q2 2026, buying an estimated $2.66M and bringing the position to 1,074,948 shares worth $60.3M. The position accounts for 0.42% of the portfolio, ranked #60.

Capital International Inc first reported a position in RPRX in Q2 2020 and has held it in 11 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Capital International Inc held 1,074,948 shares of Royalty Pharma worth $60.3M as of Q2 2026.
  • Capital International Inc bought 51,068 Royalty Pharma shares in Q2 2026, an estimated $2.66M.
  • Royalty Pharma made up 0.42% of Capital International Inc's portfolio in Q2 2026, its #60 holding.
  • Capital International Inc first reported a position in Royalty Pharma in Q2 2020 and has held it in 11 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.